New classes of chemical compounds along with more efficient methods to identify drug targets have produced exciting developments in antituberculous antibiotics. Will the new drugs now entering clinical trials have an impact on treatment?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Communicable Diseases: Achievements and Challenges for Public Health
Public Health Reviews Open Access 09 June 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
The Office of the Historian of the Public Health Service. <http://lhncbc.nlm.nih.gov/apdb/phsHistory/faqs.html> (2004).
Salomon, J.A. et al. PLoS Med. 3, e273 (2006).
Andries, K. et al. Science 307, 223–227 (2005).
Stover, C.K. et al. Nature 405, 962–966 (2000).
Matsumoto, M. et al. PLoS Med. 3, e466 (2006).
Vilcheze, C. et al. Nat. Med. 12, 1027–1029 (2006).
Rengarajan, J. et al. Mol. Microbiol. 53, 275–282 (2004).
Manjunatha, U.H. et al. Proc. Natl. Acad. Sci. USA 103, 431–436 (2006).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sassetti, C., Rubin, E. The open book of infectious diseases. Nat Med 13, 279–280 (2007). https://doi.org/10.1038/nm0307-279
Issue Date:
DOI: https://doi.org/10.1038/nm0307-279
This article is cited by
-
Communicable Diseases: Achievements and Challenges for Public Health
Public Health Reviews (2010)
-
Infectious Disease Ethics: Limiting Liberty in Contexts of Contagion
Journal of Bioethical Inquiry (2009)